Akrikhin brings to the market at least 10 products every year.
The team at Akrikhin comprises around 1500 people, 500 of whom are located in 63 regions of Russia. Akrikhin has partnerships with large international companies in contract manufacturing, including Bristol-Myers Squibb, Merck Sharp & Dohme, and Johnson & Johnson.
- 2 dose-form workshops:solids and semi-solids
- own R&D centre that has developed for production over90 new products since 2000
- Quality control laboratory. RM & FG warehouses with own customs area
- Pharmaceutical warehouse
- Akrikhin’s portfolio contains 200 products, 45% of which are included in the Essential Drugs List
AKRIKHIN celebrated its 80th anniversary in 2016. The company is actively developing, placing an emphasis on modernization and expanding production, as well as embracing new technologies. As a result, the company’s performance grows every year, in terms of both production output and sales volume.